Hong Kong Pharma Digital Technology Holdings LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Hong Kong Pharma Digital Technology Holdings Limited reported a net loss for the fiscal year ended March 31, 2025, despite an increase in total revenue, primarily due to a disproportionate rise in cost of revenues and increased operating expenses.